Search

Helpdesk

Sales contact

Home > Resources > Working with patient associations: What is the key to a positive interaction?

Working with patient associations: What is the key to a positive interaction?

Patients insights Rare disease

2 May 2023

What rare disease patients and families want is a simpler life.
Discover here what makes the relationship between the members of the patients’ association and a company work so well.

Play Video

Follow us on social media

Subscribe to our newsletter

You may also like

Rare disease clinical research: it is time to tackle what...

Biotech and eCOA vendor: A shared mindset

The client’s voice: why they consistently choose Kayentis

Why you should join Kayentis

Rethinking pediatric clinical trials: guidelines from pediatric experts

Overcoming challenges in long-lasting pediatric clinical trials – Insights from...

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Meet us at the following events

Mobile in Clinical Trials

16 SEPT 2024 • Philadelphia, USA

https://mobileinclinicaltrials.com/

DPharm 2024

17-18 SEPT 2024 • Philadelphia, USA

https://dpharmconference.com/

SCDM 2024

29 SEPT - 2 OCT 2024 • Boston, USA

https://scdmlive.org/annual-conference-2024/

ISOQOL 2024

13-16 OCT 2024 • Cologne, Germany

https://www.isoqol.org/

CNS SUMMIT 2024

10-13 NOV 2024 • Cologne, Germany

https://cnssummit.org/the-summit/

DMB 2024

13 NOV 2024 • Paris, France

https://dmb-asso.org/

SCOPE 2025

FEB 3-6 2025 • Orlando, USA

Booth #931 https://www.scopesummit.com/

Kayentis Europe
19 bis, chemin du vieux Chêne
38240 Meylan
France
Phone: +33 (0)4 76 00 54 20

Kayentis US
186 South Street
Suite 600
Boston, Massachusetts 02111
USA